Φορτώνει......
SUN-448 Giant Prolactinomas: A Follow-Up of 25 Years with Dopamine Agonists
Giant prolactinomas are tumors with a large size > 4 cm and/or prolactin levels higher than 3000 ng/ml and/or highly invasive growth. Today dopamine agonists, mainly cabergoline (CAB), are the first-line choice in the treatment of these tumors. Objective: To assess the efficacy, safety and long-t...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Endocr Soc |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Endocrine Society
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6553132/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-448 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|